SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-029456
Filing Date
2022-11-10
Accepted
2022-11-10 15:23:14
Documents
12
Period of Report
2022-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K arwr-20221109.htm   iXBRL 8-K 35596
  Complete submission text file 0001628280-22-029456.txt   175461

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arwr-20221109.xsd EX-101.SCH 1929
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arwr-20221109_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arwr-20221109_pre.xml EX-101.PRE 13064
6 EXTRACTED XBRL INSTANCE DOCUMENT arwr-20221109_htm.xml XML 11403
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 221376681
SIC: 2834 Pharmaceutical Preparations